Wuppertal, Germany

Rathindra Das


Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 42(Granted Patents)


Location History:

  • Wuppertal-Elberfeld, DE (1992)
  • Wuppertal, DE (1993 - 1995)

Company Filing History:


Years Active: 1992-1995

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Rathindra Das: Innovator in Proteinase Inhibitors

Introduction

Rathindra Das, an accomplished inventor based in Wuppertal, Germany, has made significant contributions to the field of biochemistry. With three patents to his name, his work primarily focuses on innovative proteinase inhibitors and their applications in medical science. His research and inventions are paving the way for advancements in pharmaceutical compositions.

Latest Patents

Rathindra Das's latest patents include breakthrough developments that enhance our understanding of proteinase inhibitors. One notable patent is for "Human Bikunin Variants as Proteinase Inhibitors." This invention features a proteinase inhibitor with a specific sequence of amino acids, where at least one amino acid residue has been replaced by another naturally occurring amino acid, showcasing its potential utility in pharmaceutical compositions.

Another significant invention is the "Recombinant Aprotinin Variants." This patent describes an aprotinin that includes a deletion of the amino acid proline at position 2 or an addition of alanine and glutamine. This variation demonstrates its effectiveness as an active ingredient in various medicaments.

Career Highlights

Rathindra Das is currently affiliated with Bayer Aktiengesellschaft, a leading global enterprise in the pharmaceutical industry. His work at Bayer has allowed him to leverage state-of-the-art technologies and methodologies to propel his innovative research forward. His expertise in proteinase inhibitors has notable implications for drug development and therapeutics.

Collaborations

Throughout his career, Rathindra has collaborated with esteemed professionals like Jurgen Ebbers and Dietrich Horlein. These collaborations have fostered an environment of creativity and innovation, leading to the successful r&d of his patented technologies and enhancing the overall impact on the pharmaceutical field.

Conclusion

Rathindra Das is a prominent figure in the world of biochemistry, with his patents representing significant advancements in proteinase inhibitor development. His dedication to innovation, combined with his collaborative efforts, continues to inspire progress in the pharmaceutical industry, making a real difference in the pursuit of effective medical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…